Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension

Circulation Research

Volumn 114, Issue 10, 2014, Pages 1596-1600

  Bauer, Eileen M ^a,b   Chanthaphavong, R Savanh ^a   Sodhi, Chhinder P ^a,c   Hackam, David J ^a,c   Billiar, Timothy R ^a   Bauer, Philip M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Blood platelets; Hypertension, pulmonary; Toll like receptor 4

Indexed keywords

LIPOPOLYSACCHARIDE; SEROTONIN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HYPOXIA; KNOCKOUT MOUSE; LUNG BLOOD VESSEL; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SEROTONIN RELEASE; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; THROMBOCYTE ACTIVATION; WILD TYPE;

BLOOD PLATELETS; HYPERTENSION, PULMONARY; TOLL-LIKE RECEPTOR 4;

ANIMALS; BLOOD PLATELETS; COCULTURE TECHNIQUES; GENE DELETION; HUMANS; HYPERTENSION, PULMONARY; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; RADIATION CHIMERA; TOLL-LIKE RECEPTOR 4;

EID: 84900867405     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.303662     Document Type: Article

References (20)

1. Johnson SR, Granton JT, Mehta S. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest. 2006;130:545-552
2. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499-511
3. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002;195:99-111
4. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll- like receptor 4. J Immunol. 2002;168:5233-5239
5. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279: 7370-7377
6. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem. 2002;277:15107-15112
7. Bauer EM, Shapiro R, Zheng H, Ahmad F, Ishizawar D, Comhair SA, Erzurum SC, Billiar TR, Bauer PM. High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. Mol Med. 2012;18:1509-1518
8. Young KC, Hussein SM, Dadiz R, deMello D, Devia C, Hehre D, Suguihara C. Toll-like receptor 4-deficient mice are resistant to chronic hypoxia- induced pulmonary hypertension. Exp Lung Res. 2010;36:111-119
9. Sodhi CP, Shi XH, Richardson WM, Grant ZS, Shapiro RA, Prindle T Jr, Branca M, Russo A, Gribar SC, Ma C, Hackam DJ. Toll-like receptor- 4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology. 2010;138:185-196
10. Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, Lotze MT, Geller DA, Billiar TR. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol. 2005;175:7661-7668
11. Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, Walker C, Westwick J, Thomas M. A novel murine model of severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2011;184:1171-1182
12. Bauer EM, Zheng H, Comhair S, Erzurum S, Billiar TR, Bauer PM. Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice. PLoS One. 2011;6:e28578
13. Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, Stein CS, Nieswandt B, Wang Y, Davidson BL, Ratliff TL. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity. 2003;19:9-19
14. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol. 2005;83:196-198
15. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, Ejiri J, Kobayashi S, Hirata K, Kawashima S, Yokoyama M. Expression of Toll- like receptors on human platelets. Thromb Res. 2004;113:379-385
16. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805-820
17. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol. 2009;182:7997-8004
18. Hervé P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L. Increased plasma serotonin in primary pulmonary hypertension. Am J Med. 1995;99:249-254
19. Maclean MR, Dempsie Y. The serotonin hypothesis of pulmonary hypertension revisited. Adv Exp Med Biol. 2010;661:309-322
20. Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, Rudarakanchana N, Southwood M, James V, Trembath RC, Morrell NW. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res. 2006;98:818-827